Ryan Bolden
Founder and editor
Ryan Bolden founded Mepa8 in October 2026. He is an EMS professional based in Sacramento, California. He sets the sources and rules the Mepa8 Newsroom works from, reviews published stories and handles every correction. He also builds software; his personal site is ryanbolden.com.
Stories are built from primary sources and verified against them before they publish. Read the editorial policy or contact the editor.
Stories written or edited by Ryan Bolden
- FDA launches EAST program to test drugs bought from pharmacies and wholesalers Medicine · Nov. 18, 2026 · edited
- American Regent recalls three epinephrine 30 mL vial lots over particulates and cracked vials Drugs & FDA · Nov. 18, 2026 · edited
- Danish registry study ties HeartRunner activation to higher bystander defibrillation rates EMS · Nov. 18, 2026 · edited
- FDA warns Rohto over falsified sterility records at Vietnam eye drop plant Drugs & FDA · Nov. 17, 2026 · edited
- FDA warns Ohio OTC drugmaker over lots released after failing microbial tests Medicine · Nov. 17, 2026 · edited
- Belgian study compares paramedic-only and physician-led prehospital teams across 2,325 calls EMS · Nov. 17, 2026 · edited
- Older adults' motorcycle injuries rose after Feb. 2023 earthquake, single-center study finds Medicine · Nov. 16, 2026 · edited
- Seven states report high flu activity as CDC data show early season building in South and West Public Health · Nov. 16, 2026 · edited
- FDA approves Sunharbo (asundexian), first factor XIa blocker, to prevent repeat stroke Medicine · Nov. 15, 2026 · edited
- Nursing home cardiac arrests in Japan registry had 36.3% shockable rhythms vs 7.1% at home EMS · Nov. 15, 2026 · edited
- CDC keeps Level 4 Ebola travel alert for eastern DRC as yellow fever, dengue notices update Public Health · Nov. 14, 2026 · edited
- FDA approves Gazyva as first drug for adults with primary membranous nephropathy Medicine · Nov. 14, 2026 · edited
- Japan registry study: on-scene ROSC in shockable cardiac arrest fell to 0.50% at 20 minutes EMS · Nov. 14, 2026 · edited
- About one in 10 US adults took a GLP-1 drug in the past year, CDC survey finds Public Health · Nov. 13, 2026 · edited
- FDA warns Yuan Bone joint pain product contains hidden acetaminophen, diclofenac Drugs & FDA · Nov. 13, 2026 · edited
- National EMS data show prehospital buprenorphine grew from 33 to 1,574 encounters a year EMS · Nov. 13, 2026 · edited
- CDC report counts 1,048 confirmed dengue cases and 371 hospitalizations in American Samoa Public Health · Nov. 12, 2026 · edited
- FDA warns Ismerely Mire-X joint pain product contains hidden diclofenac and dexamethasone Drugs & FDA · Nov. 12, 2026 · edited
- Korean registry study links asystole-to-PEA conversion during CPR to better neurologic outcomes EMS · Nov. 12, 2026 · edited
- FDA approves oral pimicotinib for adults with symptomatic tenosynovial giant cell tumor Medicine · Nov. 11, 2026 · edited
- UKHSA issues first yellow cold-health alert of winter for North West and West Midlands Public Health · Nov. 11, 2026 · edited
- French study finds prehospital fingerstick troponin ruled out NSTEMI in 7.1% of patients EMS · Nov. 11, 2026 · edited
- GOV.UK announces official statistics report on legionellosis in England and Wales for 2025 Public Health · Nov. 10, 2026 · edited
- MHRA lists field safety notices for Impella, Cardiosave, Lumify and saline flush syringes Drugs & FDA · Nov. 10, 2026 · edited
- CARES study of 26,895 pediatric cardiac arrests builds survival risk scores from field data EMS · Nov. 10, 2026 · edited
- Eugia recalls one lot of vancomycin 1.25 g vials nationwide after glass particle found Drugs & FDA · Nov. 9, 2026 · edited
- FDA approves Sunharbo, first factor XIa inhibitor, for secondary stroke prevention Medicine · Nov. 9, 2026 · edited
- RACE-CARS trial in 60 North Carolina counties did not improve cardiac arrest survival EMS · Nov. 9, 2026 · edited
- FDA adds DPD deficiency warnings to capecitabine and 5-FU labels, says no safe dose is proven Drugs & FDA · Nov. 7, 2026 · edited
- CDC monitored 88 U.S. contacts after Andes hantavirus outbreak on Atlantic cruise ship Public Health · Nov. 7, 2026 · edited
- Meta-analysis of 10 trials finds intranasal opioids match IV morphine for acute pain EMS · Nov. 7, 2026 · edited
- FDA grants accelerated approval to Rybrevant Faspro for recurrent head and neck cancer Medicine · Nov. 6, 2026 · edited
- NIH trial: mobile units with PrEP and opioid care cut deaths 71% among people who inject drugs Public Health · Nov. 6, 2026 · edited
- Hoisting a paramedic beat an underslung antenna in Norwegian helicopter avalanche search trial EMS · Nov. 6, 2026 · edited
- Experimental T-cell drug invika stalled tumor growth in 16 of 27 patients at optimal dose Medicine · Oct. 28, 2026 · edited
- FDA warns ZUBB weight-loss supplement contains hidden sildenafil Drugs & FDA · Oct. 28, 2026 · edited
- Review of 17,115 trauma patients finds prehospital pain drugs largely safe, evidence thin EMS · Oct. 28, 2026 · edited
- UK law adding a year of school tied to fewer dementia diagnoses in NIH-funded study Medicine · Oct. 27, 2026 · edited
- MHRA withdraws UK licence for IXCHIQ chikungunya vaccine and adds antidepressant warnings Drugs & FDA · Oct. 27, 2026 · edited
- Pilot study: transport ventilator feasible in OHCA CPR, blood gases similar to bag ventilation EMS · Oct. 27, 2026 · edited
- FDA approves Hibsago, first antisense drug for chronic hepatitis B, with boxed warning Medicine · Oct. 21, 2026 · edited
- Dispatcher and volunteer-app package raised bystander CPR in French trial but not outcomes EMS · Oct. 21, 2026 · edited
- FDA posts Class II recall of Safeguard Battle Bandage and IFAK trauma kits, 46,881 units Drugs & FDA · Oct. 21, 2026 · edited
- HeartSine's fourth AED recall since mid-2025: what samaritan PAD owners need to check EMS · Oct. 13, 2026